RxDoctor Payments Data

Melissa Noel

Gerontology · Ravenna, OHNPI 1366027096

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $4,182 of the $5,115 with a category attached, or 81.8%. 22 manufacturers reported payments, led by Inari Medical, Inc. at 33.4% of the total. Among gerontology clinicians in OH with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$5,115in general payments, 2019–2025

Across 167 payments — averaging $30.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Inari Medical, Inc.$2K
  • Atricure, Inc.$918
  • Novartis$452
  • Pfizer$319
  • Abiomed$270
  • Amgen$229
  • plus $1K from 16 others

What the payments were for

  • Travel & lodging$93318%
  • Food & beverage$4,18282%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,115 in reported general payments places this provider in the 90th percentile of 361 gerontology providers in Ohio.

See all gerontology providers in Ohio

Medicare billing

Part B allowed, 2024
$4,123
Medicare patients
52
Services billed
61

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
BrilintaTicagrelor15$15,787
EliquisApixaban14$11,480
Repatha SureclickEvolocumab12$6,440
Atorvastatin Calcium44$339
Amiodarone Hcl17$293
ClopidogrelClopidogrel Bisulfate16$120
Rosuvastatin Calcium13$110
Metoprolol Tartrate20$93
Metoprolol Succinate11$75
Isosorbide Mononitrate ErIsosorbide Mononitrate15$65
Lisinopril12$58
Amlodipine Besylate12$35
Losartan Potassium11$31

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaBrilinta$111$15,78715 claims
PfizerEliquis$319$11,48014 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 361 gerontology providers in Ohio.

Other gerontology in Ravenna

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →